Proprietary electrolyte additives for aqueous batteries, with a catalog of ~400 molecules formulated at low concentrations for precise customization. The OctoLyte® series targets zinc dendrites and hydrogen evolution, enhancing safety, lifespan, and efficiency without major cell design changes. Reported benefits: up to 20% capacity increase, 10% efficiency boost, twofold lifespan extension. Global manufacturing and distribution support integration across North America, Europe, Japan, Australia, and APAC.
OctoLyte® electrolyte additive series: proprietary molecules to prevent zinc dendrite formation and suppress parasitic hydrogen evolution in zinc-based aqueous batteries. Formulated at low concentrations for seamless integration, improving energy density, operational efficiency, and cycle life.
Awarded support under the U.S. Department of Energy’s ESTA Vouchers program in 2024; collaborations on long-duration iron battery projects with Form Energy; pilot deployments in the United States, Canada, and Europe transitioning technology from lab validation to commercial-scale testing.
Octet Scientific, Inc. has raised over $4.0M in funding from ICIG Ventures (strategic equity), BOLD Ventures (joined in 2025), the Brian Gale/Gale Family Fund (early private), JumpStart Ventures and the Advanced Manufacturing Fund ($2.0M seed), plus approximately $1.6M in government grants from the National Science Foundation (NSF), Department of Energy (DOE), and Department of Defense.
